Aflibercept ophthalmic for Macular Edema Following Retinal Vein Occlusion User Reviews
Brand names: Eylea, Eylea HD
- Ruth...
- Taken for 1 to 2 years
- December 26, 2023
Eylea (aflibercept) "I've been receiving intravitreal injections of Eylea in my right eye since April 2022, after being diagnosed with branch retinal vein occlusion. The medication seems to work well for 8-10 weeks, with central visual acuity improvement mostly stable but often deteriorating over that time frame. Noticeable side effects include a small dark spot in my visual field immediately after the injection, and recently, a dull ache in my right eye."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about aflibercept ophthalmic
- Compare alternatives
- Reviews (68)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Eylea (aflibercept) "It has helped me. My vision is not 100% but it is doing its job. I would like to keep my vision. Side effects I get are sensitivity to light, pressure, mild headache. But before I my appointment I get sensitivity to light, some blurred vision, sometimes migraine headaches. But again as soon as I get my injection after a few days my vision is good, not 100% but good."